Recommendation ID
NG140/6
Question

What is the effectiveness and safety of regimens using mifepristone and misoprostol for women who are having medical abortion after 23+6 weeks' gestation, particularly for those who have had a previous caesarean section or uterine surgery?

Any explanatory notes
(if applicable)

Source guidance details

Comes from guidance
Abortion care
Number
NG140
Date issued
September 2019

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 30/09/2019